Skała-Zamorowska Eliza, Deja Grażyna, Borowiec Maciej, Fendler Wojciech, Małachowska Beata, Kamińska Halla, Młynarski Wojciech, Jarosz-Chobot Przemysława
Department of Children Diabetology, School of Medicine in Katowice Medical University of Silesia, Poland.
Department of Clinical Genetics, Medical University of Lodz, Lodz, Poland.
Pediatr Endocrinol Diabetes Metab. 2016;22(2):54-59. doi: 10.18544/PEDM-22.02.0051.
Genetic testing in families with monogenic GCK MODY has predictive, diagnostic, and preventive utility. Predictive tests relate to people who have no features of the disorder themselves at the time of testing. Diagnostic tests relate to family members who have been previously diagnosed with diabetes mellitus or glucose metabolism disturbances. The preventive value of genetic testing for families is to raise awareness of the circumstances leading to glucose metabolism disorders.
The detection of mutation carriers among family members of patients with GCK MODY and the determination of the clinical significance of the genetic test result.
The study group included 27 families of adolescent patients with GCK MODY (39 (75%) of parents and 19 (73.08%) of siblings) monitored in the Department of Pediatrics, Endocrinology and Diabetes and in the Diabetes Clinic of John Paul II Upper Silesian Child Health Centre in Katowice in the years 2007-2012. Subjects underwent a blood sample drawing for genetic and biochemical testing.
Through the genetic diagnostics we diagnosed GCK MODY in 14 (63.64%) mothers, 6 (35.29%) fathers and in 7 (36,84%) siblings. Genetic testing has contributed to the detection of 7 (26.92%) asymptomatic carriers of GCK gene mutation among parents and 3 (15,79%) asymptomatic carriers among siblings declaring no carbohydrate metabolism disturbances (before genetic testing there were no indications suggesting carbohydrate metabolism disturbances; OGTT were performed after positive genetic testing).
Each case of mutation detection, which is the cause of monogenic diabetes in a patient, justifies the genetic testing in other members of his/her family. Awareness of the genetic status may allow sick family member to confirm the diagnosis, while asymptomatic mutation carriers could benefit from an early clinical observation. Consequently, in each case it gives an opportunity to take diagnostic and therapeutic measures in accordance with the current state of knowledge.
对单基因GCK型青少年发病的成年型糖尿病(MODY)家族进行基因检测具有预测、诊断和预防作用。预测性检测针对检测时自身没有该疾病特征的人群。诊断性检测针对先前已被诊断患有糖尿病或糖代谢紊乱的家庭成员。基因检测对家族的预防价值在于提高对导致糖代谢紊乱情况的认识。
在GCK型青少年发病的成年型糖尿病患者的家庭成员中检测突变携带者,并确定基因检测结果的临床意义。
研究组包括2007年至2012年期间在卡托维兹的约翰·保罗二世上西里西亚儿童健康中心儿科、内分泌与糖尿病科以及糖尿病诊所接受监测的27个GCK型青少年发病的成年型糖尿病青少年患者家庭(39名(75%)父母和19名(73.08%)兄弟姐妹)。受试者接受血液采样以进行基因和生化检测。
通过基因诊断,我们在14名(63.64%)母亲、6名(35.29%)父亲和7名(36.84%)兄弟姐妹中诊断出GCK型青少年发病的成年型糖尿病。基因检测促成在父母中检测出7名(26.92%)GCK基因突变无症状携带者,在宣称无碳水化合物代谢紊乱的兄弟姐妹中检测出3名(15.79%)无症状携带者(基因检测前无提示碳水化合物代谢紊乱的迹象;基因检测呈阳性后进行了口服葡萄糖耐量试验)。
在患者中检测到导致单基因糖尿病的每一例突变,都证明对其家族其他成员进行基因检测是合理的。了解基因状况可能使患病的家庭成员能够确诊,而无症状突变携带者可受益于早期临床观察。因此,在每种情况下都有机会根据当前的知识水平采取诊断和治疗措施。